COVID-19 Is Still Causing Drug Shortages That Impact Cancer Care
Experts discuss current and potential future shortages affecting the oncology field as well as strategies for preventing and managing shortages.
All articles by Victoria Forster, PhD
Lack of Mask Mandates Leaves Cancer Patients Feeling Unprotected
Cancer patients have voiced concerns about a lack of masking at cancer centers and have reported being harassed for wearing masks in public.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
OS Benefit Modest or Absent With Many High-Cost Therapies Approved for GI Malignancies
Investigators assessed disparities in patient access to therapies approved for the treatment of gastrointestinal malignancies in the United States, the United Kingdom, Europe, and Ireland, as well as benefit relative to cost.
Study Data Suggest Role for Lenvatinib in Unresectable HCC With Child-Pugh B Liver Function
Outcomes of lenvatinib-receiving patients who progressed to Child-Pugh B liver function within the first 8 weeks of treatment were compared with those of patients who maintained Child-Pugh A classification during the same time period.
American Cancer Society Updates Cervical Cancer Screening Guidelines
New guidelines from the American Cancer Society (ACS) appear to move away from the reliance on cytology screening via Pap testing.
Tocilizumab Shows Benefit in a Patient With COVID-19 and Multiple Myeloma
IL-6 blockade may have helped a patient with multiple myeloma recover from COVID-19, but larger studies are needed to prove efficacy.
Combination Therapy for Advanced Urothelial Carcinoma Shows Promise in Early Clinical Trial
A combination of pembrolizumab and an antibody-drug conjugate demonstrated a 73% overall response rate in a phase 1/2 clinical trial.
- Loading...
Loading...
Next post in Genitourinary Cancer
Loading... 
Loading...